Language:

Menu

Check the status of reimbursement of modern cancer medicines in Poland

Oncoindex indicates the scope of reimbursement for modern cancer therapies.

A negative value on the scale from -100 to 0 demonstrates how far we are from European standards of treatment.

All tumors and diseases

All tumors and diseases
Solid tumours
Haemato-oncological diseases

Show the index for a particular cancer

Show data for current Oncoindex
non-Hodgkin lymphoma
Hodgkin’s disease
Acute lymphoid leukemia
Acute myeloid leukemia
Chronic lymphoid leukemia
Chronic myeloid leukemia
Malignant prostate cancer
Malignant ovarian cancer
Colon and rectum cancer
Kidney cancer
Malignant bladder cancer
Malignant breast cancer
Tracheal, bronchus, and lung cancer
Malignant pancreatic cancer
Liver cancer
Malignant stomach cancer
Multiple myeloma and plasma cell neoplasms

Total number of substances
recommended by ESMO:

Show the list of substances

Sorry, there was a problem downloading your data.

Show the index for a particular cancer

Show data for current Oncoindex
non-Hodgkin lymphoma
Hodgkin’s disease
Acute lymphoid leukemia
Acute myeloid leukemia
Chronic lymphoid leukemia
Chronic myeloid leukemia
Malignant prostate cancer
Malignant ovarian cancer
Colon and rectum cancer
Kidney cancer
Malignant bladder cancer
Malignant breast cancer
Tracheal, bronchus, and lung cancer
Malignant pancreatic cancer
Liver cancer
Malignant stomach cancer
Multiple myeloma and plasma cell neoplasms

Select date from

March 2017
July 2018
November 2018
January 2019
May 2019
September 2019
January 2020
September 2020
January 2021

Select date to

March 2017
July 2018
November 2018
January 2019
May 2019
September 2019
January 2020
September 2020
January 2021

Sorry, there was a problem downloading your data.

Therapeutic area (cancer type)	Index value	Change in relation to previous survey

Sorry, there was a problem downloading your data.

Find out more about the Oncoindex methodology, concept and history

Discover Oncoindex